Jump to navigation Jump to search
Immtech "has an exclusive worldwide license to develop and commercialize patented compounds derived from a proprietary medicinal platform." 
Accessed March 2008: 
- Eric L. Sorkin - Chairman and Chief Executive Officer
- Cecilia Chan - Executive Director and Board Member
- David Fleet - Principal, David Fleet Pharmaceutical Industry Consultancy Services, Non-Executive Director, OnMedica Group Ltd. ,Director, IatRx Pharma Ltd.
- Judy Lau - Chairperson, Convergent Business Group, Hong Kong, PRC
- Levi Hong Kaye Lee - Queen Mary Hospital, Hong Kong, PRC
- Donald F. Sinex - Board Director, Devonwood, Inc.
- Dorothy S. Zinberg - Center for Science and International Affairs Kennedy School of Government, Harvard University
Resources and articles
Related Sourcewatch articles
- Wesley Kanne Clark - former strategic advisor